Researchers in the US now say that a drug originally developed to treat Ebola has shown positive signs in Covid-19 patients.
According to the National Institute of Allergy and Infectious Diseases (NIAID), patients hospitalised with advanced Covid-19 and lung involvement who received remdesivir recovered faster than similar patients who received a placebo.